Future study of WNT4 in ovarian cancer biology (and other gynecologic cancers) are critical to link WNT4 genotype to cancer risk, patient prognosis, therapy response, patient outcomes, and cancer health disparities. This evidence concerns the gene WNT4 and female reproductive organ cancer.